• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估抗蛇毒血清的临床前疗效:从致死性中和测定到抗蛇毒组学。

Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.

机构信息

Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.

出版信息

Toxicon. 2013 Jul;69:168-79. doi: 10.1016/j.toxicon.2012.11.016. Epub 2012 Nov 29.

DOI:10.1016/j.toxicon.2012.11.016
PMID:23201503
Abstract

The assessment of the capacity of antivenoms to neutralize the lethal activity of snake venoms is the gold standard in the preclinical analysis of antivenom efficacy, and is routinely performed by manufacturers and quality control laboratories. However, the complexity of snake venom composition and toxicological profile demands that, for many venoms, such as those of viperid snakes and some elapids, the neutralization of lethality be complemented with the analysis of the neutralization of other relevant toxic activities, such as hemorrhagic, myotoxic, necrotizing, procoagulant and defibrinogenating effects. This expanded protocol for preclinical testing of antivenoms should be used when a new antivenom is developed or when an existing antivenom is introduced in a new geographical setting for the neutralization of either homologous or heterologous venoms. In recent years, the assessment of the immunological reactivity of antivenoms has been enriched by the use of proteomic tools, with a methodology named 'antivenomics'. This allows the identification of venom components to which antivenoms have, or lack, antibodies, and thus complements the data gathered in neutralization tests, paving the way for a knowledge-based improvement of antivenom design and efficacy. International projects involving participants of manufacturing, quality control and academic research groups should be promoted in order to gain a deeper understanding on the preclinical neutralizing spectrum of antivenoms.

摘要

抗蛇毒血清中和蛇毒致死活性的能力评估是抗蛇毒血清疗效临床前分析的金标准,制造商和质量控制实验室通常都会进行这种评估。然而,蛇毒成分和毒理学特征的复杂性要求,对于许多毒液,如蝰蛇和某些眼镜蛇的毒液,在中和致死性的同时,还需要分析其他相关的毒性活性的中和作用,如出血、肌毒性、坏死、促凝和纤维蛋白溶解作用。当开发新的抗蛇毒血清或在新的地理环境中引入现有的抗蛇毒血清来中和同源或异源毒液时,应该使用这种扩展的抗蛇毒血清临床前测试方案。近年来,通过使用蛋白质组学工具,对抗蛇毒血清的免疫反应性进行了评估,这一方法被称为“抗蛇毒血清组学”。这可以鉴定抗蛇毒血清具有或缺乏抗体的毒液成分,从而补充中和试验中收集的数据,为基于知识的抗蛇毒血清设计和疗效的改进铺平道路。应该促进涉及制造商、质量控制和学术研究小组参与者的国际项目,以更深入地了解抗蛇毒血清的临床前中和谱。

相似文献

1
Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics.评估抗蛇毒血清的临床前疗效:从致死性中和测定到抗蛇毒组学。
Toxicon. 2013 Jul;69:168-79. doi: 10.1016/j.toxicon.2012.11.016. Epub 2012 Nov 29.
2
Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.抗蛇毒血清的免疫学特征:通过抗蛇毒血清组学和中和试验对多价抗蛇毒血清疗效进行临床前分析。
J Proteomics. 2014 Jun 13;105:340-50. doi: 10.1016/j.jprot.2014.02.021. Epub 2014 Feb 28.
3
Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.抗蛇毒血清治疗蛇咬伤中毒疗效的临床前评估:现状与未来挑战
Toxins (Basel). 2017 May 13;9(5):163. doi: 10.3390/toxins9050163.
4
Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.抗蛇毒血清组学与六种拉丁美洲抗蛇毒血清对产自哥伦比亚西南部的矛头蝮属asper 种系蛇毒的体内临床前疗效评价。
PLoS Negl Trop Dis. 2021 Feb 1;15(2):e0009073. doi: 10.1371/journal.pntd.0009073. eCollection 2021 Feb.
5
Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study.澳大利亚抗蛇毒血清对来自巴布亚新几内亚的小眼蛇(Micropechis ikaheka)毒液的临床前疗效:抗蛇毒血清组学与中和研究
J Proteomics. 2014 Oct 14;110:198-208. doi: 10.1016/j.jprot.2014.06.016. Epub 2014 Jun 28.
6
Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays.针对 Cerrophidion sasai、Porthidium nasutum 和 Porthidium ophryomegas 毒液的多特异性抗蛇毒血清的临床前评估:结合抗蛇毒组学和中和测定的见解。
Toxicon. 2013 Mar 15;64:60-9. doi: 10.1016/j.toxicon.2012.12.024. Epub 2013 Jan 10.
7
Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.秘鲁和哥斯达黎加生产的多价抗蛇毒血清对四种秘鲁矛头蝮蛇毒的中和作用:临床前评估
Acta Trop. 2005 Jan;93(1):85-95. doi: 10.1016/j.actatropica.2004.09.008.
8
Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review.拉丁美洲和加勒比地区蛇毒抗血清中和效力的临床前评估:综述
Toxicon. 2018 May;146:138-150. doi: 10.1016/j.toxicon.2018.02.053. Epub 2018 Mar 3.
9
Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria.对在撒哈拉以南非洲分发的四种抗蛇毒血清中和来自马里、喀麦隆和尼日利亚的地毯蝰蛇(Echis ocellatus)毒液的临床前疗效进行评估。
Toxicon. 2015 Nov;106:97-107. doi: 10.1016/j.toxicon.2015.09.027. Epub 2015 Sep 28.
10
Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics.三种多特异性抗蛇毒血清对锯鳞蝰蛇毒液的临床前评估:毒性活性的中和作用及抗蛇毒血清组学
Toxicon. 2016 Sep 1;119:280-8. doi: 10.1016/j.toxicon.2016.06.022. Epub 2016 Jul 1.

引用本文的文献

1
Current Technologies in Snake Venom Analysis and Applications.蛇毒分析及应用的当前技术。
Toxins (Basel). 2024 Oct 25;16(11):458. doi: 10.3390/toxins16110458.
2
Immunological Cross-Reactivity and Preclinical Assessment of a Colombian Anticoral Antivenom against the Venoms of Three Species.免疫交叉反应性和一种哥伦比亚抗眼镜蛇抗蛇毒血清对三种蛇种毒液的临床前评估。
Toxins (Basel). 2024 Feb 15;16(2):104. doi: 10.3390/toxins16020104.
3
Machine-learning guided Venom Induced Dermonecrosis Analysis tooL: VIDAL.基于机器学习的毒液诱导皮肤坏死分析工具:VIDAL。
Sci Rep. 2023 Dec 8;13(1):21662. doi: 10.1038/s41598-023-49011-6.
4
Snakebite envenoming in Brazilian children: clinical aspects, management and outcomes.巴西儿童蛇伤中毒:临床特征、处理及结局
J Trop Pediatr. 2023 Feb 6;69(2). doi: 10.1093/tropej/fmad010.
5
Evaluation of lethality and cytotoxic effects induced by (large brown spitting cobra) venom and the envenomation-neutralizing efficacy of selected commercial antivenoms in Kenya.肯尼亚对(大棕喷毒眼镜蛇)毒液诱导的致死性和细胞毒性作用以及所选商业抗蛇毒血清的抗蛇毒效果进行评估。
Toxicon X. 2022 May 4;14:100125. doi: 10.1016/j.toxcx.2022.100125. eCollection 2022 Jun.
6
Immunorecognition and Neutralization of Venom by a Commercial Antivenom Produced in Colombia.免疫识别与中和毒液的商业抗毒液生产在哥伦比亚。
Toxins (Basel). 2022 Mar 25;14(4):235. doi: 10.3390/toxins14040235.
7
as an animal model for the preliminary evaluation of snake venom-induced toxicity.作为蛇毒诱导毒性初步评估的动物模型。
Toxicon X. 2021 Aug 19;12:100082. doi: 10.1016/j.toxcx.2021.100082. eCollection 2021 Nov.
8
Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles.评估蛇抗蛇毒血清中和能力的检测方法:朝着 3R 原则发展。
Front Immunol. 2021 Jan 11;11:617429. doi: 10.3389/fimmu.2020.617429. eCollection 2020.
9
Peptide Inhibitors of the α-Cobratoxin-Nicotinic Acetylcholine Receptor Interaction.α-眼镜蛇毒素-烟碱型乙酰胆碱受体相互作用的肽抑制剂。
J Med Chem. 2020 Nov 25;63(22):13709-13718. doi: 10.1021/acs.jmedchem.0c01202. Epub 2020 Nov 3.
10
An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management.对撒哈拉以南非洲抗蛇毒血清的临床前疗效测试分析:缺乏独立的审查和低质量的报告是改善蛇咬伤治疗和管理的障碍。
PLoS Negl Trop Dis. 2020 Aug 20;14(8):e0008579. doi: 10.1371/journal.pntd.0008579. eCollection 2020 Aug.